BUDESONIDE

budesonide 1 mg orally disintegrating tablet, 60

BUDESONIDE (12982G)

budesonide 1 mg orally disintegrating tablet, 60
12982G
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Eosinophilic oesophagitis
Treatment phase: Subsequent continuing treatment - Maintenance of remission
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $415.21 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Jorveza